A phase 2 trial of leflunomide, pomalidomide, and dexamethasone for relapsed/refractory multiple myeloma

Clinical Lymphoma Myeloma and Leukemia(2023)

引用 0|浏览22
暂无评分
关键词
relapsed/refractory relapsed/refractory multiple myeloma,multiple myeloma,pomalidomide,dexamethasone
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要